Clinical Trials for NsGene

Explore 3 clinical trials worldwide

Showing 1-3 of 3 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruitingSponsor: NsGene

Clinical Trials (3)

NCT04725331
A Clinical Trial Assessing BT-001 Alone and in Combination With Pembrolizumab in Metastatic or Advanced Solid Tumors
PHASE1/PHASE2Recruiting
48 participants
Started: Feb 25, 2021 · Completed: Apr 30, 2025
6 conditions3 sponsors5 locations
NCT04183166
A Clinical Trial Evaluating TG4050 in Head and Neck Cancer
PHASE1/PHASE2Active, not recruiting
80 participants
Started: Dec 12, 2019 · Completed: Dec 30, 2028
1 condition1 sponsor14 locations
NCT03260023
Phase Ib/II of TG4001 and Avelumab in HPV16 Positive R/M Cancers
PHASE1/PHASE2Active, not recruiting
150 participants
Started: Sep 11, 2017 · Completed: Dec 31, 2025
5 conditions4 sponsors20 locations